Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of digital biomarkers of disease progression for digital phenotyping of patients with arterial hypertension.

VASA. Zeitschrift fur Gefasskrankheiten - 1 Nov 2024

Kasimovskaya Nataliya, Fomina Elena, Krivetskaya Maria, Diatlova Ekaterina, Egorova Elena, Pavlov Dmitry

Abstract excerpt

Background: To compare the effectiveness of digital phenotyping of patients diagnosed with arterial hypertension with traditional monitoring methods over a three-year period. Patients and methods: The study was conducted from January 2021 to January 2024 among 800 patients diagnosed with arterial hypertension at 6 clinics in Moscow, Russia, evenly divided into experimental (identification of digital biomarkers of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arterial Pressure
Share to Blood Pressure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exercise

Share to Healthy Lifestyle

Share to Hypertension

Share to Predictive Value of Tests

Share to Risk Reduction Behavior

Source

Identifiers

PMID: 39390963
DOI: 10.1024/0301-1526/a001155

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of digital biomarkers of disease progression for digital phenotyping of patients with arterial hypertension.PMID 39390963Read ↗

The prediction of cardiovascular events by phenotype of central and peripheral blood pressure in subjects without hypertensionSemantic proximity Read ↗

Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH GuidelinesSemantic proximity Read ↗

Beyond the 2025 guidelines: tailoring hypertension management to the underlying pathogenic pathway in the age of precision medicine.Semantic proximity Read ↗

Comparison of cardiovascular risk in individuals with normal vs isolated elevated diastolic blood pressureSemantic proximity Read ↗

Validation of the Hanvon KSY8600 Blood Pressure Monitor in the General Population Based on AAMI/ESH/ISO (ISO 81060-2:2018) + AMD1:2020 ProtocolSemantic proximity Read ↗

Hemodynaomics Map: A Machine Learning-Derived Functional Hemodynamic Framework for Mechanism-Guided Hypertension ManagementSemantic proximity Read ↗

A photoplethysmography-based aging clock reveals genetic determinants of arterial agingSemantic proximity Read ↗

Distribution of cardiovascular disease risk based on the updated 2023 guideline-recommended Australian cardiovascular disease risk algorithm and comparison with the 2012 algorithmSemantic proximity Read ↗

Improvements in blood and fitness tracker biomarkers in a longitudinal real-world cohort of digital health platform usersSemantic proximity Read ↗

Predicting the risk of incident hypertension and increase in blood pressure: A systematic review of existing prediction models for adultsSemantic proximity Read ↗

Discovery of New Blood Pressure Phenotypes and Relation to Accuracy of Cuff Devices Used in Daily Clinical Practice.Semantic proximity Read ↗

Early Detection of Cardiovascular Disease Risk Using Multi-Parameter Biomarker Analysis and Machine Learning: A Prospective Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.